Taurine and oxidative stress in retinal health and disease.


Journal

CNS neuroscience & therapeutics
ISSN: 1755-5949
Titre abrégé: CNS Neurosci Ther
Pays: England
ID NLM: 101473265

Informations de publication

Date de publication:
04 2021
Historique:
received: 20 11 2020
revised: 19 12 2020
accepted: 21 12 2020
pubmed: 24 2 2021
medline: 13 1 2022
entrez: 23 2 2021
Statut: ppublish

Résumé

Retinal disorders are leading causes of blindness and are due to an imbalance between reactive oxygen species and antioxidant scavenger (in favor of pro-oxidant species) or a disruption of redox signaling and control. Indeed, it is well known that oxidative stress is one of the leading causes of retinal degenerative diseases. Different approaches using nutraceuticals resulted in protective effects in these disorders. This review will discuss the impact of oxidative stress in retinal neurodegenerative diseases and the potential strategies for avoiding or counteracting oxidative damage in retinal tissues, with a specific focus on taurine. Increasing data indicate that taurine may be effective in slowing down the progression of degenerative retinal diseases, thus suggesting that taurine can be a promising candidate for the prevention or as adjuvant treatment of these diseases. The mechanism by which taurine supplementation acts is mainly related to the reduction of oxidative stress. In particular, it has been demonstrated to improve retinal reduced glutathione, malondialdehyde, superoxide dismutase, and catalase activities. Antiapoptotic effects are also involved; however, the protective mechanisms exerted by taurine against retinal damage remain to be further investigated.

Identifiants

pubmed: 33621439
doi: 10.1111/cns.13610
pmc: PMC7941169
doi:

Substances chimiques

Reactive Oxygen Species 0
Taurine 1EQV5MLY3D

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-412

Informations de copyright

© 2021 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.

Références

Brain Res. 1972 Jun 22;41(2):494-7
pubmed: 5038343
Stroke. 2019 Aug;50(8):2197-2206
pubmed: 31242827
Ophthalmology. 2015 Jul;122(7):1471-9
pubmed: 25972257
Sci Rep. 2018 Jun 6;8(1):8675
pubmed: 29875478
Amino Acids. 2014 Jan;46(1):89-100
pubmed: 23933994
J Optom. 2018 Jan - Mar;11(1):3-9
pubmed: 28760643
Psychol Health Med. 2015;20(3):296-310
pubmed: 25034616
Neuron. 2012 Oct 18;76(2):266-80
pubmed: 23083731
Sci Rep. 2020 Jan 17;10(1):545
pubmed: 31953470
Am J Ophthalmol. 2008 May;145(5):879-82
pubmed: 18329624
Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2967-71
pubmed: 10967052
Drug Des Devel Ther. 2016 Jun 02;10:1857-67
pubmed: 27330279
Curr Opin Pharmacol. 2013 Feb;13(1):36-42
pubmed: 23009741
Curr Drug Targets. 2005 Jun;6(4):511-24
pubmed: 16026270
Free Radic Res. 2003 Mar;37(3):323-30
pubmed: 12688428
PLoS One. 2012;7(10):e42017
pubmed: 23115615
Invest Ophthalmol Vis Sci. 2005 Mar;46(3):877-83
pubmed: 15728543
Int J Nanomedicine. 2007;2(1):65-77
pubmed: 17722514
J Leukoc Biol. 1995 Dec;58(6):667-74
pubmed: 7499964
Ophthalmology. 2013 Apr;120(4):844-51
pubmed: 23332590
Invest Ophthalmol Vis Sci. 2013 May 09;54(5):3333-9
pubmed: 23599328
Annu Rev Vis Sci. 2019 Sep 15;5:15-45
pubmed: 31525142
Diabetes. 2004 Dec;53(12):3233-8
pubmed: 15561955
Amino Acids. 2012 Nov;43(5):1979-93
pubmed: 22476345
Neurochem Res. 1992 Jun;17(6):599-604
pubmed: 1603266
Pharmacol Rep. 2006 May-Jun;58(3):353-63
pubmed: 16845209
Cell Rep. 2020 Feb 18;30(7):2209-2224.e5
pubmed: 32075760
Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1396-1409
pubmed: 29625463
Nat Rev Neurol. 2013 Jan;9(1):44-53
pubmed: 23165340
Antioxidants (Basel). 2020 Apr 23;9(4):
pubmed: 32340220
Oxid Med Cell Longev. 2016;2016:3164734
pubmed: 26881021
Front Immunol. 2019 Aug 20;10:1975
pubmed: 31481963
Oxid Med Cell Longev. 2016;2016:8590578
pubmed: 28116038
J Ophthalmic Vis Res. 2018 Apr-Jun;13(2):158-169
pubmed: 29719645
CNS Neurosci Ther. 2016 Jan;22(1):7-14
pubmed: 26507240
Biochemistry. 2005 Jan 18;44(2):480-9
pubmed: 15641772
Invest Ophthalmol Vis Sci. 1981 Nov;21(5):714-27
pubmed: 7298275
JAMA Ophthalmol. 2014 Mar;132(3):272-7
pubmed: 24385141
J Cardiovasc Dis Res. 2011 Apr;2(2):96-103
pubmed: 21814413
Aging Cell. 2002 Dec;1(2):117-23
pubmed: 12882341
Cell Transplant. 2020 Jan-Dec;29:963689720905805
pubmed: 32098493
Ophthalmology. 2019 Nov;126(11):1541-1548
pubmed: 31358387
Drug Des Devel Ther. 2019 Aug 07;13:2689-2702
pubmed: 31496648
Free Radic Biol Med. 1997;22(4):587-92
pubmed: 9013121
Retina. 2007 Jan;27(1):10-2
pubmed: 17218909
CNS Neurosci Ther. 2013 Nov;19(11):889-96
pubmed: 23981689
Life Sci. 2005 Jan 14;76(9):1051-60
pubmed: 15607333
CNS Neurosci Ther. 2018 May;24(5):448-455
pubmed: 29372592
Annu Rev Genet. 2009;43:95-118
pubmed: 19659442
N Engl J Med. 2000 Feb 17;342(7):483-92
pubmed: 10675430
Amino Acids. 2012 Jun;42(6):2223-32
pubmed: 21691752
Am J Med. 2003 Jun 1;114(8):638-46
pubmed: 12798451
Ophthalmic Res. 2010;44(3):179-90
pubmed: 20829642
N Engl J Med. 2012 Mar 29;366(13):1227-39
pubmed: 22455417
Expert Opin Pharmacother. 2009 Nov;10(16):2663-77
pubmed: 19874249
J Biol Chem. 1995 Apr 28;270(17):10017-26
pubmed: 7730303
Animal Model Exp Med. 2018 Mar;1(1):7-13
pubmed: 29863179
Arch Ophthalmol. 2001 Oct;119(10):1417-36
pubmed: 11594942
Cold Spring Harb Perspect Med. 2014 Jul 03;4(8):
pubmed: 24993677
Amino Acids. 2000;19(3-4):527-46
pubmed: 11140357
J Biol Chem. 2017 Jul 21;292(29):12054-12064
pubmed: 28578316
Diabetes. 2006 Nov;55(11):3112-20
pubmed: 17065350
PLoS One. 2016 Nov 28;11(11):e0167181
pubmed: 27893849
Oxid Med Cell Longev. 2017;2017:9208489
pubmed: 28194256
Oxid Med Cell Longev. 2017;2017:4076518
pubmed: 28424744
Neurochem Res. 2004 Jan;29(1):151-60
pubmed: 14992274
Cell Mol Neurobiol. 2008 Jun;28(4):593-611
pubmed: 17712625
Arch Ophthalmol. 2005 Apr;123(4):458-63
pubmed: 15824217
Cochrane Database Syst Rev. 2017 Jul 30;7:CD000253
pubmed: 28756617
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Neuron. 2014 Feb 5;81(3):641-52
pubmed: 24507195
Cells. 2020 Feb 25;9(3):
pubmed: 32106630
CNS Neurosci Ther. 2020 Jun 20;:
pubmed: 32562453
Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1865-79
pubmed: 16987039
Antioxid Redox Signal. 2015 Jul 20;23(3):239-55
pubmed: 25178482
J Cell Physiol. 1999 Aug;180(2):182-9
pubmed: 10395288
Mol Cell Neurosci. 2010 Oct;45(2):192-9
pubmed: 20599618
Curr Eye Res. 2011 Dec;36(12):1069-77
pubmed: 21978133
J Pharmacol Sci. 2006 Aug;101(4):335-43
pubmed: 16891764
Eye (Lond). 2001 Jun;15(Pt 3):384-9
pubmed: 11450762
CNS Neurosci Ther. 2020 Jun 19;:
pubmed: 32562344
Annu Rev Vis Sci. 2015 Nov 24;1:263-289
pubmed: 28532365
EMBO Mol Med. 2018 Oct;10(10):
pubmed: 30224384
Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34
pubmed: 11033038
Invest Ophthalmol Vis Sci. 1983 Sep;24(9):1283-7
pubmed: 6885312
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3805-11
pubmed: 17652755
Ann Med. 2006;38(7):450-71
pubmed: 17101537
Biomed Res Int. 2014;2014:801269
pubmed: 25105142
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):694-701
pubmed: 14744916
Mol Vis. 2012;18:2673-86
pubmed: 23170060
J Clin Med. 2019 Sep 04;8(9):
pubmed: 31487953
Biochim Biophys Acta. 2009 Oct;1790(10):1109-16
pubmed: 19409449
Surv Ophthalmol. 2002 Dec;47 Suppl 2:S263-9
pubmed: 12507628
Exp Mol Pathol. 2003 Aug;75(1):95-108
pubmed: 12834631
Acta Ophthalmol. 2018 Mar;96(2):e237-e241
pubmed: 28772005
Curr Eye Res. 1995 Aug;14(8):693-701
pubmed: 8529405
Front Mol Neurosci. 2019 May 28;12:132
pubmed: 31191244
Arch Ophthalmol. 2009 Apr;127(4):533-40
pubmed: 19365036
Adv Ther. 2020 Jan;37(1):113-139
pubmed: 31782132
Exp Eye Res. 2017 Apr;157:20-27
pubmed: 28242160
Biofactors. 1999;10(2-3):157-67
pubmed: 10609877
Ophthalmology. 1984 Jun;91(6):564-79
pubmed: 6462622
J Investig Med. 2004 Jan;52(1):33-44
pubmed: 14989368
Neural Regen Res. 2018 Nov;13(11):2014-2021
pubmed: 30233077
J Biol Chem. 2016 May 13;291(20):10501-14
pubmed: 27008858
Biomol Ther (Seoul). 2018 May 1;26(3):225-241
pubmed: 29631391
CNS Neurosci Ther. 2021 Apr;27(4):403-412
pubmed: 33621439
Adv Exp Med Biol. 2017;975 Pt 2:687-701
pubmed: 28849492
Curr Eye Res. 2020 Jan;45(1):52-63
pubmed: 31404506
Nutr Rev. 2003 Oct;61(10):342-6
pubmed: 14604266
Cell Death Dis. 2018 Jan 25;9(2):119
pubmed: 29371661
Vision Res. 2004;44(17):2091-100
pubmed: 15149840
Diabetes Res Clin Pract. 2003 Apr;60(1):1-9
pubmed: 12639759
Hum Mol Genet. 2020 Mar 13;29(4):618-623
pubmed: 31903486

Auteurs

Vanessa Castelli (V)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Antonella Paladini (A)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Michele d'Angelo (M)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Marcello Allegretti (M)

Dompé Farmaceutici SpA, L'Aquila, Italy.

Flavio Mantelli (F)

Dompé Farmaceutici SpA, L'Aquila, Italy.

Laura Brandolini (L)

Dompé Farmaceutici SpA, L'Aquila, Italy.

Pasquale Cocchiaro (P)

Dompé Farmaceutici SpA, L'Aquila, Italy.

Annamaria Cimini (A)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, PA, USA.

Giustino Varrassi (G)

Paolo Procacci Foundation, Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH